BTIG reiterates Buy rating on Abivax, $175 target
BTIG reiterated a Buy rating on Abivax and set a $175.00 price target, implying 93.1% upside from the Sep 21 close of $90.65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.